Vasoactive intestinal peptide analogs
    2.
    发明授权
    Vasoactive intestinal peptide analogs 失效
    血管活性肠肽类似物

    公开(公告)号:US06489297B1

    公开(公告)日:2002-12-03

    申请号:US09630335

    申请日:2000-07-31

    IPC分类号: A61K3816

    摘要: The present invention encompasses novel analogs of vasoactive intestinal peptide (VIP), containing substitutions at appropriately selected amino acids. The invention particularly relates to the design and synthesis of novel biologically active VIP analogs containing &agr;,&agr;-dialkylated amino acids in a site-specific manner. Specifically, the invention relates to the synthesis of VIP peptide derivatives, which bind selectively to VIP receptors on target cells. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer,

    摘要翻译: 本发明包括血管活性肠肽(VIP)的新类似物,其在适当选择的氨基酸处含有取代。 本发明特别涉及以位点特异性方式设计和合成含有α,α-二烷基化氨基酸的新型生物活性VIP类似物。 具体而言,本发明涉及VIP靶衍生物的合成,VIP衍生物选择性结合靶细胞上的VIP受体。 本发明包括产生这些肽的方法,含有肽的组合物和这些肽的药理学应用,特别是在治疗和预防癌症中,

    Somatostatin analogs for the treatment of cancer
    3.
    发明授权
    Somatostatin analogs for the treatment of cancer 失效
    生长抑素类似物用于治疗癌症

    公开(公告)号:US06316414B1

    公开(公告)日:2001-11-13

    申请号:US09629371

    申请日:2000-07-31

    IPC分类号: A61K3800

    CPC分类号: C07K14/6555 A61K38/00

    摘要: The present invention encompasses novel peptides that are agonists to somatostatin and the use of the agonists for treatment of cancer. The invention particularly relates to the design and synthesis of novel analogs of somatostatin incorporating &agr;, &agr;-dialkylated amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

    摘要翻译: 本发明包括作为促生长抑素激动剂的新型肽以及激动剂用于治疗癌症的用途。 本发明特别涉及以特异性位点结合α,α-二烷基化氨基酸的生长抑素的新型类似物的设计和合成。 本发明包括产生这些肽的方法,含有肽的组合物和这些肽的药理学应用,特别是在治疗和预防癌症中。

    Bombesin analogs for treatment of cancer
    4.
    发明授权
    Bombesin analogs for treatment of cancer 失效
    用于治疗癌症的Bombesin类似物

    公开(公告)号:US06989371B1

    公开(公告)日:2006-01-24

    申请号:US09630333

    申请日:2000-07-31

    IPC分类号: A61K38/00 C07K7/00

    CPC分类号: C07K7/086 A61K38/00

    摘要: The present invention encompasses novel peptides that are antagonists to bombesin and bombesin like peptides and are useful in the treatment of cancer. The invention particularly relates to the design and synthesis of the novel peptides incorporating α,α-amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

    摘要翻译: 本发明包括作为铃蟾肽和铃蟾肽样肽的拮抗剂的新型肽,并且可用于治疗癌症。 本发明特别涉及以位点特异性方式结合α,α-氨基酸的新型肽的设计和合成。 本发明包括产生这些肽的方法,含有肽的组合物和这些肽的药理学应用,特别是在治疗和预防癌症中。

    Peptides for treatment of cancer
    7.
    发明授权
    Peptides for treatment of cancer 失效
    用于治疗癌症的肽

    公开(公告)号:US06828304B1

    公开(公告)日:2004-12-07

    申请号:US09630345

    申请日:2000-07-31

    IPC分类号: A61K3800

    摘要: This invention relates to novel antiproliferative and anti secrectory peptides that are inhibitory to vasoactive intestinal peptide receptor and are useful in the treatment of cancer. The invention particularly relates to the synthesis of lipid-peptide conjugates containing fatty acids of different sizes, which inhibits the binding of VIP to its receptors. The invention encompasses methods for generation of these peptides, composition containing these peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

    摘要翻译: 本发明涉及抑制血管活性肠肽受体并可用于治疗癌症的新型抗增殖和抗分解肽。 本发明特别涉及含有不同大小的脂肪酸的脂质 - 肽缀合物的合成,其抑制VIP与其受体的结合。 本发明包括用于产生这些肽的方法,含有这些肽的组合物以及这些肽的药理学应用,特别是在治疗和预防癌症中。

    Anticancer activity of imino acid conjugates or methylglyoxal
    10.
    发明授权
    Anticancer activity of imino acid conjugates or methylglyoxal 失效
    甲基乙二醛的亚氨基酸共轭物的抗癌活性

    公开(公告)号:US06613793B2

    公开(公告)日:2003-09-02

    申请号:US10187420

    申请日:2002-07-01

    IPC分类号: A61K3140

    CPC分类号: C07D207/28

    摘要: The invention relates to the use of imino acid conjugates of methylglyoxal for the inhibition and/or treatment of cancer. The invention relates more specifically to the use imino acid conjugates of methylglyoxal for inhibition and/or treatment of cancer of the Colon, Prostate, Larynx, Kidney, Pancreas, Lung, Breast, Intestine, Oral cavity, Ovary, Glioblastoma, and Leukemia. The invention also relates to compositions and methods of inhibiting cancer using imino acid conjugates of methylglyoxal.

    摘要翻译: 本发明涉及甲基乙二醛的亚氨基酸偶联物用于抑制和/或治疗癌症的用途。 本发明更具体地涉及使用甲基乙二醛的亚氨基酸缀合物用于抑制和/或治疗结肠,前列腺,喉,肾,胰腺,肺,乳腺,肠,口腔,卵巢,成胶质细胞瘤和白血病的癌症。 本发明还涉及使用甲基乙二醛的亚氨基酸缀合物抑制癌症的组合物和方法。